These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 11956993)
1. The role of survivin as a new target of diagnosis and treatment in human cancer. Yamamoto T; Tanigawa N Med Electron Microsc; 2001 Dec; 34(4):207-12. PubMed ID: 11956993 [TBL] [Abstract][Full Text] [Related]
2. Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond. Chiou SK; Jones MK; Tarnawski AS Med Sci Monit; 2003 Apr; 9(4):PI25-9. PubMed ID: 12709681 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583 [TBL] [Abstract][Full Text] [Related]
4. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells. Zhou M; Gu L; Li F; Zhu Y; Woods WG; Findley HW J Pharmacol Exp Ther; 2002 Oct; 303(1):124-31. PubMed ID: 12235242 [TBL] [Abstract][Full Text] [Related]
5. [Research advances on inhibitor of apoptosis, survivin]. Yang J; Liu FX; Yan XC Ai Zheng; 2003 Jul; 22(7):771-4. PubMed ID: 12866973 [TBL] [Abstract][Full Text] [Related]
6. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Olie RA; Simões-Wüst AP; Baumann B; Leech SH; Fabbro D; Stahel RA; Zangemeister-Wittke U Cancer Res; 2000 Jun; 60(11):2805-9. PubMed ID: 10850418 [TBL] [Abstract][Full Text] [Related]
7. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells. Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567 [TBL] [Abstract][Full Text] [Related]
8. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target. Capalbo G; Rödel C; Stauber RH; Knauer SK; Bache M; Kappler M; Rödel F Strahlenther Onkol; 2007 Nov; 183(11):593-9. PubMed ID: 17960333 [TBL] [Abstract][Full Text] [Related]
9. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018 [TBL] [Abstract][Full Text] [Related]
10. Structural, functional and therapeutic biology of survivin. Sah NK; Khan Z; Khan GJ; Bisen PS Cancer Lett; 2006 Dec; 244(2):164-71. PubMed ID: 16621243 [TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453 [TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo. Zhang M; Mukherjee N; Bermudez RS; Latham DE; Delaney MA; Zietman AL; Shipley WU; Chakravarti A Prostate; 2005 Aug; 64(3):293-302. PubMed ID: 15754318 [TBL] [Abstract][Full Text] [Related]
13. Regulation of microtubule stability and mitotic progression by survivin. Giodini A; Kallio MJ; Wall NR; Gorbsky GJ; Tognin S; Marchisio PC; Symons M; Altieri DC Cancer Res; 2002 May; 62(9):2462-7. PubMed ID: 11980633 [TBL] [Abstract][Full Text] [Related]
14. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Mahotka C; Wenzel M; Springer E; Gabbert HE; Gerharz CD Cancer Res; 1999 Dec; 59(24):6097-102. PubMed ID: 10626797 [TBL] [Abstract][Full Text] [Related]
15. Survivin, versatile modulation of cell division and apoptosis in cancer. Altieri DC Oncogene; 2003 Nov; 22(53):8581-9. PubMed ID: 14634620 [TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides. Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801 [TBL] [Abstract][Full Text] [Related]
17. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer. Hou JQ; He J; Wang XL; Wen DG; Chen ZX Chin Med J (Engl); 2006 Oct; 119(20):1734-9. PubMed ID: 17097022 [TBL] [Abstract][Full Text] [Related]
18. Correlation between survivin mRNA expression and homoharringtonine induced apoptosis of malignant hematopoietic cells. Cai Z; Bao HY; Lin MF Chin Med J (Engl); 2005 Apr; 118(7):548-54. PubMed ID: 15820085 [TBL] [Abstract][Full Text] [Related]
19. Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. Wang HW; Sharp TV; Koumi A; Koentges G; Boshoff C EMBO J; 2002 Jun; 21(11):2602-15. PubMed ID: 12032073 [TBL] [Abstract][Full Text] [Related]
20. Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells. Pratt MA; Niu MY; Renart LI Apoptosis; 2006 Apr; 11(4):589-605. PubMed ID: 16528475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]